These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10206383)

  • 21. Efficacy of sotalol guided by programmed electrical stimulation for sustained ventricular arrhythmias secondary to coronary artery disease.
    Young GD; Kerr CR; Mohama R; Boone J; Yeung-Lai-Wah JA
    Am J Cardiol; 1994 Apr; 73(9):677-82. PubMed ID: 8166065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy of empirical chronic amiodarone therapy in patients with sustained ventricular tachyarrhythmia and structural heart disease.
    Aiba T; Kurita T; Taguchi A; Shimizu W; Suyama K; Aihara N; Kamakura S
    Circ J; 2002 Apr; 66(4):367-71. PubMed ID: 11954951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
    Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
    Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ
    Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of electrophysiologic properties between responders and non-responders to DL-sotalol among patients with ventricular tachyarrhythmia. Importance of the lack of a reverse use-dependent effect on ventricular refractoriness to responders.
    Naitoh N; Yamaura M; Tagawa M; Aizawa Y
    Jpn Heart J; 1998 Sep; 39(5):619-30. PubMed ID: 9925993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
    Mooss AN; Wurdeman RL; Sugimoto JT; Packard KA; Hilleman DE; Lenz TL; Rovang KS; Arcidi JM; Mohiuddin SM
    Am Heart J; 2004 Oct; 148(4):641-8. PubMed ID: 15459595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiodarone versus sotalol for atrial fibrillation.
    Singh BN; Singh SN; Reda DJ; Tang XC; Lopez B; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Raisch DW; Ezekowitz MD;
    N Engl J Med; 2005 May; 352(18):1861-72. PubMed ID: 15872201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia.
    Shiga T; Hosaka F; Wakaumi M; Matsuda N; Tanizaki K; Kajimoto K; Shoda M; Hagiwara N; Kasanuki H
    Cardiovasc Drugs Ther; 2003 Jul; 17(4):325-33. PubMed ID: 14618094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
    Klein RC
    Eur Heart J; 1993 Nov; 14 Suppl H():78-84. PubMed ID: 8293756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug therapy of ventricular arrhythmias].
    Hohnloser SH
    Med Klin (Munich); 1997 Apr; 92(4):208-10. PubMed ID: 9221302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia.
    Kotake Y; Kurita T; Akaiwa Y; Yasuoka R; Motoki K; Kobuke K; Iwanaga Y; Miyazaki S
    J Cardiol; 2015 Aug; 66(2):161-7. PubMed ID: 25468767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome.
    Meierhenrich R; Helguera ME; Kidwell GA; Tebbe U
    Int J Cardiol; 1997 Aug; 60(3):289-94. PubMed ID: 9261640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of aconitine induced life threatening ventricular tachyarrhythmia with amiodarone.
    Yeih DF; Chiang FT; Huang SK
    Heart; 2000 Oct; 84(4):E8. PubMed ID: 10995426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blockers for ventricular arrhythmias: have we underestimated their value?
    Campbell TJ
    Aust N Z J Med; 1996 Oct; 26(5):689-96. PubMed ID: 8958366
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of efficacy of sotalol and nifekalant for ventricular tachyarrhythmias.
    Watanabe H; Chinushi M; Washizuka T; Sugiura H; Hirono T; Aizawa Y; Komura S; Hosaka Y; Tanabe Y; Furushima H; Aizawa Y
    Circ J; 2006 May; 70(5):583-7. PubMed ID: 16636494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.